The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

At top AI labs, the future looks either fantastically bright—or terrifyingly dark. More in today’s TIME tech newsletter.

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

Trump’s new COVID-19 website features five arguments supporting the lab. Among them was the explanation that Wuhan – the Chinese city where the virus first began spreading – is home to a ...

The newest variant — NB.1.8.1. or “Nimbus” — may cause painful sore throats, earning it a new nickname: “razor blade throat” COVID.

Press Releases With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides’ Dr. Diwan ACCESS Newswire ...